Fed Grow Pharmaceuticals is setting out to re-define well-being by acting as the leading scientific hub to bring products to market that address large unmet needs and advance the quality of life for patients who have no other alternatives.
Get updates about our company and related news about canabis. Get exclusive access when we launch new products
Since 2017 Fed Grow has helped 3 companies obtain their DEA Registrations as a Schedule 1 manufacturer, specializing in the cultivation, processing, and manufacturing of pharmaceutical-grade phytobase therapeutics.
Our focus is straightforward: providing researchers and drug developers with diverse compositions to advance scientific and medical research globally.
Our mission is clear – to redefine well-being through the production of high-quality botanical-based medications.
Fed Grow Pharmaceuticals has positioned itself to operate and is highly invested in the following key licenses that enhance its capabilities and competitive advantage in the botanical market. These licenses enable legal and effective operation, provide strategic benefits in supply chain control, market expansion, and research, and ensure compliance. They collectively boost the company’s value proposition by fostering innovation and supporting its mission to develop high-quality, pharmaceutical-grade botanical products.
We are a DEA-registered Schedule I Bulk Manufacturer, providing botanical raw material and extracts to qualified researchers and drug developers.
Our products are cultivated and manufactured following strict Good Manufacturing Practices (GMP) and Good Agricultural & Collection Practices (GACP), ensuring high-quality and consistent products.
Allows Royal Emerald to bulk manufacture botanical extracts and compounds, and distribute them to DEA-licensed researchers. This license is crucial for conducting extensive research and developing new drug formulations.
Permits the distribution and transport of Class II-V drugs across state lines, enabling Royal Emerald to expand its market reach and supply chain efficiency.
Permits the distribution, brokerage, or transaction of Class I-V drugs or devices in California, broadening the company’s distribution capabilities within the state.
Got a specific question? Feel free to give us a shout!
22525 SE 64th Pl, Issaquah,
WA 98027